Wells Fargo Maintains Nvidia’s $185 Price Target
- Rating
- Overweight
- Unchanged
- Target
- $185
- Outcome
- Reached
- on September 30, 2025
Wells Fargo’s latest target on NVIDIA is now $250 (Nov 18, 2026); the median of 36 firms is $228. Wells Fargo has reached 69% of its year-old targets (45 scored).

What the analyst said
Wells Fargo analyst Aaron Rakers reiterated on May 29, 2025, a ‘Overweight’ rating on Nvidia. The price target of $185 was reaffirmed.
“Our Call
NVDA F1Q26 results + F2Q26 guide reinforce confidence in a materializing Blackwell ramp (70% of DC compute), networking momentum, path to mid-70%, & more. Tomorrow we’re hosting a mtg w/ CFO Colette Kress on Wells Annual Silicon Valley Bus Tour.
What Matters Most
- Data Center Blackwell Ramp Is On: NVDA F1Q26 Data Center rev. at $39.1128, + 73% y/y and +10% q/q vs our 538.98 est (Street @ $39.3B). As previewed, NVDA provided positive comments on building Blackwell ramp — ~ 70% of Compute, or implying ~$248 vs rptd -511B in F4Q25.
- China H20 Ban Impact: NVDA incurred a $4.5B charge vs. initial $5.5B guided. NVDA was unable to ship -$2.5B in F1Q26 (shipped $4.6B): guided -$8B loss in F2Q26 w/no planned replacement
- Networking: Rev at $4.957B, +56% y/y and +64% q/q: driven by growth of NVLink compute fabric via GB200 rack-scale + Spectrum-X momentum at hyperscalers.Spectrum-X now at +$8B/annum w/ Meta and GCP added as customers. We’ve had a lot of lateral q’s on Arista implications (note: we’re mtg w/ ANET tomorrow).
- GM% Guide to 72% +/-50bps; Mid-70% in 2HFY26 (Unchanged): Blackwell ramp driving modest q/q improvement; reiterated return to mid-70% into 2HFY26. Note:F1Q26 net provision ~$4.9B, -11pp.
F2Q26 Guide: NVIDIA is guiding F2Q26 rev at $45B +/- 2%, GM% at ~ 72% +/- 50bps,| and ~$4B opex vs prior Street (VisibleApha) at ~$42.8B / 73.1% / $3.9B. With an OI&E at ~$450M and a 16.5% (+/- 1%) tax rate, we arrive at an implied F2Q26 non-GAAP EPS at ~$0.94-$1.02 (prior Street @ $0.99/sh). NVDA expects modest q/q growth across all platforms.
With shares of NVDA now trading at 24x and 21x our CY26 & CY27, respectively — or more notably trading near a trough relative P/E to SOX (2 st. deviations below 5-yr median), we reiterate our OW rating and $185 PT. We think investor sentiment will now shift back toward a path to +$6/sh. CY26 EPS.
We move our FY26, FY27, and FY28 ests. from $189.6B / $4.07, $242.0B / $5.60, and $285.98 / $6.58 to $200.6B / $4.37, $256.9B / $6.00, and $303.1B / $7.05. Maintain $185 PT.
F1Q26 Results Summary
- NVIDIA reported F1 Q26 rev. / non-GAAP EPS at $44.062B / $0.81 vs our $42.94B / $0.74 est. (Street: $43.38B / $0.87): pre-H20 ban rev. guide at $43.0B (+/-2%).
- F1Q26 GM% at 61% compared to our 58.7% est. & ~71.0% +/- 50bps pre-H20 ban guide (note: ~1,030 bps GM% impact via disclosed $4.54B inventory.)
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
NVDA trades at $126. The 36 analysts who set a target in the last 3 months range from $135 to $350, with a median of $228. This $185 target is 19% below the median.
Since the note NVDA has moved −7% (from $135). The 12-month window closed on May 29, 2026.
Track record
This call✓ Target reached on September 30, 2025, 4 months after the note. Same target as this firm’s May 21, 2025 note, so it is scored there.
Firm track recordWells Fargo: 69% of its 45 targets at least a year old were reached within 12 months (#25 of 29 firms); on NVIDIA, 3 of 4. Accuracy ranking →
Wells Fargo on NVIDIA
Wells Fargo price targets on NVIDIA
6 calls from December 29, 2025 to November 18, 2026. The target went from $265 to $250 (−6%). The rating stayed Buy.




